| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.25B | +10.0% |
| R&D Expense | $107.2M | -3.9% |
| SG&A Expense | $146.9M | -0.7% |
| Operating Income | $1.21B | +12.6% |
| Interest Expense | $171.6M | +7.5% |
| Pre-tax Income | $1.04B | +21.6% |
| Income Tax | $173.3M | +31.1% |
| Net Income | $870.6M | +19.9% |
| EPS (Basic) | $10.78 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $993.6M | -30.1% |
| Accounts Receivable | $663.2M | -0.2% |
| Current Assets | $1.75B | -18.4% |
| Total Assets | $5.00B | -9.2% |
| Current Liabilities | $1.25B | -0.0% |
| Long-term Debt | $4.51B | +8.4% |
| Total Liabilities | $6.01B | +5.9% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.10B | +17.0% |
| Capital Expenditures | $13.6M | +0.8% |
| Investing Cash Flow | -$79.3M | +92.3% |
| Financing Cash Flow | -$1.43B | -721.1% |
| Free Cash Flow | $1.08B | +17.3% |
| +22.5% |
| EPS (Diluted) | $10.72 | +23.2% |
| Stockholders' Equity |
| -$1.01B |
| -516.6% |